Biologicals

Technical report series: cytokines

Biological products, rDNA

Title: Biological products prepared by recombinant DNA technology; Adopted 1990, TRS No 814, Annex 3

Interferons, human

Title: Requirements for Human Interferons prepared from Lymphoblastoid Cells; Adopted 1988, TRS No 786, Annex 3

Interferons, human

Title: Requirements for Human interferons made by recombinant DNA techniques; Adopted 1987, TRS No 771, Annex 7

Upcoming events

WHO Informal Consultation on Regulatory considerations for evaluation of Ebola Vaccines intended for emergency use, WHO/HQ Geneva, Switzerland, 18-19 March 2015

WHO Informal Consultation on Stability Evaluation of Vaccines for use in a Controlled Temperature Chain, WHO/HQ Geneva, Switzerland, 24–26 March 2015

WHO Informal Consultation on Amendment for Similar Biotherapeutic products of monoclonal antibodies, WHO/HQ Geneva, Switzerland, 27–28 April 2015

WHO Informal Consultation on Regulatory risk assessment for biotherapeutic products, WHO/HQ Geneva, Switzerland, 29–30 April 2015

Contacts

Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971